Logo image of XMTR

XOMETRY INC-A (XMTR) Stock Fundamental Analysis

NASDAQ:XMTR - Nasdaq - US98423F1093 - Common Stock - Currency: USD

31.31  -0.96 (-2.97%)

After market: 31.31 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to XMTR. XMTR was compared to 48 industry peers in the Trading Companies & Distributors industry. XMTR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XMTR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year XMTR has reported negative net income.
XMTR had a negative operating cash flow in the past year.
In the past 5 years XMTR always reported negative net income.
XMTR had a negative operating cash flow in each of the past 5 years.
XMTR Yearly Net Income VS EBIT VS OCF VS FCFXMTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

The Return On Assets of XMTR (-7.53%) is worse than 93.62% of its industry peers.
XMTR has a Return On Equity of -16.20%. This is amonst the worse of the industry: XMTR underperforms 91.49% of its industry peers.
Industry RankSector Rank
ROA -7.53%
ROE -16.2%
ROIC N/A
ROA(3y)-10.69%
ROA(5y)-23.39%
ROE(3y)-18.43%
ROE(5y)-40.07%
ROIC(3y)N/A
ROIC(5y)N/A
XMTR Yearly ROA, ROE, ROICXMTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -20 -40 -60 -80

1.3 Margins

XMTR has a better Gross Margin (39.17%) than 68.09% of its industry peers.
In the last couple of years the Gross Margin of XMTR has grown nicely.
XMTR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.77%
GM growth 5YN/A
XMTR Yearly Profit, Operating, Gross MarginsXMTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

XMTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
XMTR has more shares outstanding than it did 1 year ago.
The debt/assets ratio for XMTR is higher compared to a year ago.
XMTR Yearly Shares OutstandingXMTR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M 40M
XMTR Yearly Total Debt VS Total AssetsXMTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

XMTR has an Altman-Z score of 2.85. This is not the best score and indicates that XMTR is in the grey zone with still only limited risk for bankruptcy at the moment.
XMTR has a Altman-Z score (2.85) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.90 indicates that XMTR is somewhat dependend on debt financing.
The Debt to Equity ratio of XMTR (0.90) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z 2.85
ROIC/WACCN/A
WACC10.11%
XMTR Yearly LT Debt VS Equity VS FCFXMTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

XMTR has a Current Ratio of 4.59. This indicates that XMTR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.59, XMTR belongs to the best of the industry, outperforming 93.62% of the companies in the same industry.
A Quick Ratio of 4.55 indicates that XMTR has no problem at all paying its short term obligations.
XMTR has a better Quick ratio (4.55) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.59
Quick Ratio 4.55
XMTR Yearly Current Assets VS Current LiabilitesXMTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 82.35% over the past year.
The Revenue has grown by 21.16% in the past year. This is a very strong growth!
Measured over the past years, XMTR shows a very strong growth in Revenue. The Revenue has been growing by 48.54% on average per year.
EPS 1Y (TTM)82.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)21.16%
Revenue growth 3Y48.54%
Revenue growth 5YN/A
Sales Q2Q%19.15%

3.2 Future

The Earnings Per Share is expected to grow by 53.83% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 17.76% on average over the next years. This is quite good.
EPS Next Y80.31%
EPS Next 2Y65.71%
EPS Next 3Y53.83%
EPS Next 5YN/A
Revenue Next Year17.31%
Revenue Next 2Y18.21%
Revenue Next 3Y17.68%
Revenue Next 5Y17.76%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
XMTR Yearly Revenue VS EstimatesXMTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
XMTR Yearly EPS VS EstimatesXMTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

XMTR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 104.94, the valuation of XMTR can be described as expensive.
Based on the Price/Forward Earnings ratio, XMTR is valued expensively inside the industry as 80.85% of the companies are valued cheaper.
When comparing the Price/Forward Earnings ratio of XMTR to the average of the S&P500 Index (22.65), we can say XMTR is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 104.94
XMTR Price Earnings VS Forward Price EarningsXMTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XMTR Per share dataXMTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
XMTR's earnings are expected to grow with 53.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y65.71%
EPS Next 3Y53.83%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XMTR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XOMETRY INC-A

NASDAQ:XMTR (2/24/2025, 8:03:30 PM)

After market: 31.31 0 (0%)

31.31

-0.96 (-2.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)11-05 2024-11-05/bmo
Earnings (Next)02-25 2025-02-25/bmo
Inst Owners95.19%
Inst Owner Change-94.66%
Ins Owners6.23%
Ins Owner Change4.91%
Market Cap1.55B
Analysts80
Price Target35.7 (14.02%)
Short Float %8.5%
Short Ratio5.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)138.45%
Min EPS beat(2)92.16%
Max EPS beat(2)184.74%
EPS beat(4)4
Avg EPS beat(4)74.27%
Min EPS beat(4)8.12%
Max EPS beat(4)184.74%
EPS beat(8)7
Avg EPS beat(8)47.39%
EPS beat(12)10
Avg EPS beat(12)38.79%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.97%
Min Revenue beat(2)0.89%
Max Revenue beat(2)1.05%
Revenue beat(4)3
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)1.05%
Revenue beat(8)4
Avg Revenue beat(8)-1.14%
Revenue beat(12)7
Avg Revenue beat(12)-0.48%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.02%
PT rev (3m)53.01%
EPS NQ rev (1m)9.64%
EPS NQ rev (3m)52.36%
EPS NY rev (1m)2.72%
EPS NY rev (3m)18.1%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)0.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 104.94
P/S 2.95
P/FCF N/A
P/OCF N/A
P/B 4.92
P/tB 80.66
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)0.3
Fwd EY0.95%
FCF(TTM)-0.92
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS10.6
BVpS6.36
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.53%
ROE -16.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.17%
FCFM N/A
ROA(3y)-10.69%
ROA(5y)-23.39%
ROE(3y)-18.43%
ROE(5y)-40.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.77%
GM growth 5YN/A
F-Score4
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 160.92%
Cap/Sales 3.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.59
Quick Ratio 4.55
Altman-Z 2.85
F-Score4
WACC10.11%
ROIC/WACCN/A
Cap/Depr(3y)173.53%
Cap/Depr(5y)160.06%
Cap/Sales(3y)3.48%
Cap/Sales(5y)3.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
EPS Next Y80.31%
EPS Next 2Y65.71%
EPS Next 3Y53.83%
EPS Next 5YN/A
Revenue 1Y (TTM)21.16%
Revenue growth 3Y48.54%
Revenue growth 5YN/A
Sales Q2Q%19.15%
Revenue Next Year17.31%
Revenue Next 2Y18.21%
Revenue Next 3Y17.68%
Revenue Next 5Y17.76%
EBIT growth 1Y32.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.77%
EBIT Next 3Y73.93%
EBIT Next 5Y64.01%
FCF growth 1Y47.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.41%
OCF growth 3YN/A
OCF growth 5YN/A